Anti-SC6A2/ NET/ SLC6A2 monoclonal antibody
Anti-SC6A2/ NET/ SLC6A2 antibody for FACS & in-vivo assay
Go to NET/SLC6A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T21945-Ab-1/ GM-Tg-hg-T21945-Ab-2 | Anti-Human NET/SLC6A2 monoclonal antibody | Human |
GM-Tg-rg-T21945-Ab-1/ GM-Tg-rg-T21945-Ab-2 | Anti-Rat NET/SLC6A2 monoclonal antibody | Rat |
GM-Tg-mg-T21945-Ab-1/ GM-Tg-mg-T21945-Ab-2 | Anti-Mouse NET/SLC6A2 monoclonal antibody | Mouse |
GM-Tg-cynog-T21945-Ab-1/ GM-Tg-cynog-T21945-Ab-2 | Anti-Cynomolgus/ Rhesus macaque NET/SLC6A2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T21945-Ab-1/ GM-Tg-felg-T21945-Ab-2 | Anti-Feline NET/SLC6A2 monoclonal antibody | Feline |
GM-Tg-cang-T21945-Ab-1/ GM-Tg-cang-T21945-Ab-2 | Anti-Canine NET/SLC6A2 monoclonal antibody | Canine |
GM-Tg-bovg-T21945-Ab-1/ GM-Tg-bovg-T21945-Ab-2 | Anti-Bovine NET/SLC6A2 monoclonal antibody | Bovine |
GM-Tg-equg-T21945-Ab-1/ GM-Tg-equg-T21945-Ab-2 | Anti-Equine NET/SLC6A2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T21945-Ab-1/ GM-Tg-hg-T21945-Ab-2; GM-Tg-rg-T21945-Ab-1/ GM-Tg-rg-T21945-Ab-2; GM-Tg-mg-T21945-Ab-1/ GM-Tg-mg-T21945-Ab-2; GM-Tg-cynog-T21945-Ab-1/ GM-Tg-cynog-T21945-Ab-2; GM-Tg-felg-T21945-Ab-1/ GM-Tg-felg-T21945-Ab-2; GM-Tg-cang-T21945-Ab-1/ GM-Tg-cang-T21945-Ab-2; GM-Tg-bovg-T21945-Ab-1/ GM-Tg-bovg-T21945-Ab-2; GM-Tg-equg-T21945-Ab-1/ GM-Tg-equg-T21945-Ab-2 |
Products Name | Anti-NET/SLC6A2 monoclonal antibody |
Format | mab |
Target Name | NET |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-NET benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species SC6A2/ NET/ SLC6A2 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLPm005238 | mouse Slc6a2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm005238 | mouse Slc6a2 Lentivirus particle |
Target information
Target ID | GM-T21945 |
Target Name | NET |
Gene ID | 6530,20538,83511,613238,487272,101099605,282363,100061346 |
Gene Symbol and Synonyms | NAT,NAT-1,NAT1,NE-T,NET,NET1,SLC6A2,SLC6A5 |
Uniprot Accession | P23975,O62696,P51143 |
Uniprot Entry Name | SC6A2_HUMAN,ARY1_FELCA,SC6A2_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000103546 |
Target Classification | N/A |
The target: NET, gene name: SLC6A2, also named as NAT1, NET, NET1, SLC6A5. This gene encodes a member of the sodium:neurotransmitter symporter family. This member is a multi-pass membrane protein, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis. Mutations in this gene cause orthostatic intolerance, a syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.